Jennifer McKie Adams
CIK: 0001851440
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Eton Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jul 31, 2026ETON
Eton Pharmaceuticals, Inc.
Award(A)DirectCommon Stock
10K shares- - Jun 17, 2026ETON
Eton Pharmaceuticals, Inc.
Exercise(M)Direct50K shares at avg. $3.78$189K - Jun 17, 2026ETON
Eton Pharmaceuticals, Inc.
Sale(S)Direct50K shares at avg. $32.48$1.6M - Jan 12, 2026ETON
Eton Pharmaceuticals, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
12.2K shares- - Jan 12, 2026ETON
Eton Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
7.8K shares- - Jan 3, 2025ETON
Eton Pharmaceuticals, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
25K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 31, 2026 | ETON Eton Pharmaceuticals, Inc. | Award(A) Common Stock | 10,000 | - | - | Direct |
| Jun 17, 2026 | ETON Eton Pharmaceuticals, Inc. | Exercise(M) | 50,000 | $3.78 | $189,000 | Direct |
| Jun 17, 2026 | ETON Eton Pharmaceuticals, Inc. | Sale(S) | 50,000 | $32.48 | $1,623,795 | Direct |
| Jan 12, 2026 | ETON Eton Pharmaceuticals, Inc. | Award(A) Employee Stock Option (Right to Buy) | 12,196 | - | - | Direct |
| Jan 12, 2026 | ETON Eton Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 7,757 | - | - | Direct |
| Jan 3, 2025 | ETON Eton Pharmaceuticals, Inc. | Award(A) Employee Stock Option (Right to Buy) | 25,000 | - | - | Direct |
1-6 of 6 transactions
About Adams Jennifer McKie
Adams Jennifer McKie (SEC CIK 0001851440) files insider reports with the SEC as Director of Eton Pharmaceuticals, Inc. (ETON).
Signal8 holds 4 ownership filings by Adams Jennifer McKie, all Form 4s, filed between Jan 6, 2025 and Aug 4, 2026. Those filings report 6 transactions, from Jan 3, 2025 to Jul 31, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Adams Jennifer McKie's filings is in DEERPARK, IL.
Recent filings by Adams Jennifer McKie
- Jul 31, 2026: Grant or award of ETON derivative securities (Form 4, code A).
- Jun 17, 2026: Option exercise of ETON shares (Form 4, code M).
- Jun 17, 2026: Open-market sale of ETON shares (Form 4, code S).
- Jan 12, 2026: Grants or awards of ETON derivative securities (2 lines, Form 4, code A).
- Jan 3, 2025: Grant or award of ETON derivative securities (Form 4, code A).
Other insiders filing for Eton Pharmaceuticals, Inc. (ETON)
- Krempa David, Chief Business Officer
- MAIER PAUL V, Director
- BRYNJELSEN SEAN, President & CEO
- Radosavljevic Danka, Chief Operating Officer
- CASAMENTO CHARLES J, Director
- Matthews Judith M., Chief Financial Officer